Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline
The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Abstract
OBJECTIVE The aim was to update The Endocrine Society Clinical Practice Guideline on Evaluation and Treatment of Adult Growth Hormone Deficiency (GHD) previously published in 2006. CONSENSUS PROCESS Consensus was guided by systematic reviews of evidence and discussions through a series of conference calls and e-mails. An initial draft was prepared by the Task Force, with the help of a medical writer, and reviewed and commented on by members of The Endocrine Society. A second draft was reviewed and approved by The Endocrine Society Council. At each stage of review, the Task Force received written comments and incorporated substantive changes. CONCLUSIONS GHD can persist from childhood or be newly acquired. Confirmation through stimulation testing is usually required unless there is a proven genetic/structural lesion persistent from childhood. GH therapy offers benefits in body composition, exercise capacity, skeletal integrity, and quality of life measures and is most likely to benefit those patients who have more severe GHD. The risks associated with GH treatment are low. GH dosing regimens should be individualized. The final decision to treat adults with GHD requires thoughtful clinical judgment with a careful evaluation of the benefits and risks specific to the individual.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GHD in particular has a wide range of test methodology and diagnostic thresholds employed across studies, despite agreement among global guidelines [26 · , 64-67] as to what constitutes deficiency.”
From Neuroendocrine Disruptions Following Head Injury (2023) · cites this paper as [65]
In the citing paper
“For the diagnosis of TBI-induced GHD, the ITT and the GHRHϩARG test are now considered as the tests of choice with similar accuracy (194,215).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
In the citing paper
“The glucagon stimulation test (GST) (1 mg glucagon im, GH measurements every 30 min until 240 min after administration) has been proposed as an alternative diagnostic because it is able to differentiate between GH-deficient and healthy subjects with a sensitivity and specificity of 100% if a peak GH of 3 g/L is considered (215, 226).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
In the citing paper
“For the ITT, peak GH response levels lower than 3 g/L indicate severe GHD in adults (if hypoglycemia is adequately reached) (194,215).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
In the citing paper
“Therefore, in the latest Endocrine Society guideline on the evaluation and treatment of adult GHD, as part of their standard clinical care, patients with severe GHD (diagnosed by appropriate dynamic tests and with relevant clinical features) were recommended individualized physiological doses of recombinant GH treatment (215).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [215]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Gamma knife radiosurgery for trigeminal neuralgia associated with multiple sclerosis
Rogers, L., Shetter, A. G., Ponce, F. A., Fiedler, J. A., Smith, K. A., & Speiser, B. L. (2002) · Journal of neurosurgery · doi:10.3171/jns.2002.97.supplement_5.0529 · Cited by 1,773
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402 · cited 1×
“hypogonadal men received testosterone replacement (154).”
Salomon, F., Cuneo, R. C., Hesp, R., & Sönksen, P. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912283212605 · Cited by 1,326
The Role of Carotid Arterial Intima-Media Thickness in Predicting Clinical Coronary Events
Hodis, H. N., Mack, W. J., LaBree, L., Selzer, R. H., Liu, C.-R., Liu, C.-H., & Azen, S. P. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-4-199802150-00002 · Cited by 1,217 · cited 1×
“In epidemiological studies, increases in IMT have predicted the development of symptomatic coronary disease occurring approximately 8 yr after the initial measurements (137).”
Association between premature mortality and hypopituitarism
Tomlinson, J., Holden, N., Hills, R., Wheatley, K., Clayton, R., Bates, A., Sheppard, M., & Stewart, P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04006-x · Cited by 1,006
BENEFICIAL EFFECTS OF GROWTH HORMONE TREATMENT IN GH-DEFICIENT ADULTS
Jørgensen, J. O. L., Thuesen, L., Ingemann-Hansen, T., Pedersen, S. A., Jørgensen, I., Skakkebaek, N. E., & Christiansen, J. S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92328-3 · Cited by 890
Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review
Carroll, P. V., Christ the members of Growth Hormon, E. R., Bengtsson, B. Å., Carlsson, L., Christiansen, J. S., Clemmons, D., Hintz, R., Ho, K., Laron, Z., Sizonenko, P., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4594 · Cited by 822
Self-citationTreatment of adults with growth hormone (GH) deficiency with recombinant human GH.
Bengtsson, B. A., Edén, S., Lönn, L., Kvist, H., Stokland, A., Lindstedt, G., Bosaeus, I., Tölli, J., Sjöström, L., & Isaksson, O. G. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.2.8432773 · Cited by 778
Clinical Aspects of Growth Hormone Deficiency in Adults
BOER, H. D., BLOK, G.-J., & DER VEEN, E. A. V. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-63 · Cited by 723
Cited by
Items 301–400 of 1,000
Pituitary Disorders in Pregnancy
Woodmansee, W. W. (2018) · Neurologic Clinics · doi:10.1016/j.ncl.2018.09.009 · Cited by 32
The Potential Role of Growth Hormone on the Endometrium in Assisted Reproductive Technology
Liu, F.-T., Wu, Z., Yan, J. Y., Norman, R. J., & Li, R. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00049 · Cited by 26
Profka, E., Rodari, G., Giacchetti, F., & Giavoli, C. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.678778 · Cited by 27
Acylated ghrelin as a provocative test for the diagnosis of GH deficiency in adults
Gasco, V., Beccuti, G., Baldini, C., Prencipe, N., Giacomo, S. D., Berton, A. M., Guaraldi, F., Tabaro, I., Maccario, M., Ghigo, E., et al. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0584 · Cited by 28
Human growth hormone measurement by means of a sensitive ELISA of whole blood spots on filter paper
Langkamp, M., Weber, K., & Ranke, M. B. (2008) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2008.04.007 · Cited by 26
Grugni, G., Giardino, D. L., Crinò, A., Malvestiti, F., Ballarati, L., Giorgio, G. D., & Marzullo, P. (2011) · Journal of Endocrinological Investigation · doi:10.3275/7203 · Cited by 28
Growth hormone delivery devices: current features and potential for enhanced treatment adherence
Rohrer, T. R., Horikawa, R., & Kappelgaard, A. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2017.1243526 · Cited by 27
Giavoli, C., Profka, E., Verrua, E., Ronchi, C. L., Ferrante, E., Bergamaschi, S., Sala, E., Malchiodi, E., Lania, A. G., Arosio, M., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2477 · Cited by 25
Carosi, G., Malchiodi, E., Ferrante, E., Sala, E., Verrua, E., Profka, E., Giavoli, C., Filopanti, M., Beck‐Peccoz, P., Spada, A., et al. (2015) · Neuroendocrinology · doi:10.1159/000430815 · Cited by 28
Pituitary incidentalomas: A guide to assessment, treatment and follow-up
Paschou, S. Α., Vryonidou, A., & Goulis, D. G. (2016) · Maturitas · doi:10.1016/j.maturitas.2016.08.006 · Cited by 26
Contribution of Ghrelin to the Pathogenesis of Growth Hormone Deficiency
Lewiñski, A., Karbownik‐Lewińska, M., Wieczorek, K., Stasiak, M., & Stawerska, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22169066 · Cited by 32
“1 ng/mL—Biller, 2002; Molitch, 2011 [41,47] <3 ng/mL—Ho, 2007 [42] <5 ng/mL—Yuen, 2019 [43]”
BackgroundHan, A. J., Varlamov, E. V., & Fleseriu, M. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab748 · Cited by 28
Gordon, M., Levy, R., Gut, R., & Germak, J. (2016) · Endocrine Practice · doi:10.4158/ep14603.or · Cited by 20
Carminucci, A. S., Ausiello, J. C., Page‐Wilson, G., Lee, M., Good, L., Bruce, J. N., & Freda, P. U. (2015) · Endocrine Practice · doi:10.4158/ep15894.or · Cited by 26
Wilson, J. R., Utz, A. L., & Devin, J. K. (2015) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2015.12.005 · Cited by 26
Gunn, M. E., Malila, N. K., Lähdesmäki, T., Arola, M. O., Grönroos, M. H., Matomäki, J., & Lähteenmäki, P. M. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov115 · Cited by 34
Capalbo, D., Barbieri, F., Improda, N., Giallauria, F., Di Pietro, E., Rapacciuolo, A., Di Mase, R., Vigorito, C., & Salerno, M. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00871 · Cited by 24
“To evaluate the LV function and structure, we measured the following: (1) LV end diastolic diameter (LVEDD) and LV end systolic diameter (LVESD), by M-mode parasternal short axis view; (2) LV mass (LVM), by M-mode parasternal short axis view (measuring septal, IVST, and posterior wall thickness, LVPWT); (3) LVFS perce…”
BackgroundMethodResultInfluentialLanglois, F., Manea, A., Lim, D. S. T., McCartney, S., Yedinak, C. G., Cetas, J. S., & Fleseriu, M. (2018) · Endocrine · doi:10.1007/s12020-018-1784-0 · Cited by 26
Sheehan syndrome: a current approach to a dormant disease
Karaca, Z., & Keleştimur, F. (2025) · Pituitary · doi:10.1007/s11102-024-01481-1 · Cited by 32
“Dose adjustment should be based upon clinic response and IGF-1 levels [98].”
Toogood, A. A., Brabant, G. E., Maiter, D. M., Jonsson, B., Feldt‐Rasmussen, U., Kołtowska‐Häggström, M., Rasmussen, Å. K., Buchfelder, M., Saller, B., & Biller, B. M. K. (2011) · Endocrine Practice · doi:10.4158/ep11146.or · Cited by 24
Yuen, K. C. J., Masel, B. E., Reifschneider, K. L., Sheffield-Moore, M., Urban, R. J., & Pyles, R. B. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa398 · Cited by 24
Sabbah, N., Wolf, P. S., Piedvache, C., Trabado, S., Verdelet, T., Cornu, C., Souberbielle, J., & Chanson, P. (2021) · Endocrine Connections · doi:10.1530/ec-21-0175 · Cited by 28
Takahashi, Y. (2023) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2023.101816 · Cited by 29
Ospina, N. S., Rodríguez‐Gutiérrez, R., Brito, J. P., Young, W. F., & Montori, V. M. (2015) · BMC Medicine · doi:10.1186/s12916-015-0435-z · Cited by 28
Stanhope, R. G., Sörgel, F., Gravel, P., Schuetz, Y. B., Zabransky, M., & Muenzberg, M. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009359005 · Cited by 24
Newman, C. B., Frisch, K. A., Rosenzweig, B. P., Roubenoff, R., Rey, M. J., Kidder, T., Kong, Y., Pursnani, A. K., Sedlis, S. P., Schwartzbard, A. Z., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1204 · Cited by 24
Yuen, K. C. J. (2011) · ISRN Endocrinology · doi:10.5402/2011/608056 · Cited by 24
New Developments in the Illegal Provision of Growth Hormone for “Anti-Aging” and Bodybuilding
Olshansky, S. J. (2008) · JAMA · doi:10.1001/jama.299.23.2792 · Cited by 24
Management of GH treatment in adult GH deficiency
Gasco, V., Caputo, M., Lanfranco, F., Ghigo, E., & Grottoli, S. (2017) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2017.03.001 · Cited by 27
Hypopituitarism in the Elderly: Multifaceted Clinical and Biochemical Presentation
Foppiani, L., Ruelle, A., Bandelloni, R., Quilici, P., & Monte, P. D. (2008) · Current Aging Science · doi:10.2174/1874609810801010042 · Cited by 25
Aspectos diagnósticos e terapêuticos da síndrome de Sheehan
Soares, D. V., Conceição, F. L., & Vaisman, M. (2008) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302008000500020 · Cited by 24
Clinical Characteristics and Pituitary Dysfunction in Patients with Metastatic Cancer to the sella
Ariel, D., Sung, H., Coghlan, N., Dodd, R. L., Gibbs, I. C., & Katznelson, L. J. (2013) · Endocrine Practice · doi:10.4158/ep12407.or · Cited by 24
Neuroendocrine Disruptions Following Head Injury
Wexler, T. L. (2023) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-023-01263-5 · Cited by 23
Donze, S., Damen, L., van der Velden, J. A. E. M., Bocca, G., Finken, M. J. J., Hoorweg-Nijman, G., Jira, P. E., van Leeuwen, M., & Hokken-Koelega, A. (2019) · Clinical Endocrinology · doi:10.1111/cen.13988 · Cited by 23
Long-term neuroendocrine consequences of traumatic brain injury and strategies for management
Hacıoğlu, A., Keleştimur, F., & Tanrıverdi, F. (2020) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2020.1733411 · Cited by 23
“Detailed information about interpretation of the test results and comparison between the tests in terms of advantages and pitfalls can be obtained elsewhere [84,85].”
BackgroundAssessment of non-traumatic vertebral fractures in Cushing’s syndrome patients
Apaydın, T., & Yavuz, D. G. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01496-y · Cited by 25
Garmes, H. M., Boguszewski, C. L., Miranda, P. A. C., Martins, M. R. A., Correa‐Silva, S. R., Abucham, J., Musolino, N. R. D. C., Vilar, L., Portari, L. H. C., Gadelha, M. R., et al. (2021) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000335 · Cited by 31
The physiology of growth hormone (GH) in adults: translational journey to GH replacement therapy
Ho, K. K. Y., O’Sullivan, A., & Burt, M. G. (2022) · Journal of Endocrinology · doi:10.1530/joe-22-0197 · Cited by 32
The influence of growth hormone deficiency on bone health and metabolism
Wydra, A., Czajka-Oraniec, I., Wydra, J., & Zgliczyński, W. (2023) · Reumatologia/Rheumatology · doi:10.5114/reum/170244 · Cited by 33
Explaining Long COVID: A Pioneer Cross-Sectional Study Supporting the Endocrine Hypothesis
Ach, T., Slama, N. B. H., Gorchane, A., Abdelkrim, A. B., Garma, M., Lasfar, N. B., Bellazreg, F., Debbabi, W., Hachfi, W., Chaieb, M. C., et al. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae003 · Cited by 26
“A decrease in IGF-1 is highly suggestive of GHD, especially when other anterior pituitary axes are affected [24].”
BackgroundMethodInfluentialYuen, K. C. J., Bennett, R. M., Hryciw, C. A., Cook, M. B., Rhoads, S. A., & Cook, D. M. (2007) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2006.12.006 · Cited by 24
Hypopituitarism in the elderly
Antonopoulou, M., Sharma, R. K., Farag, A., Banerji, M. A., & Karam, J. G. (2012) · Maturitas · doi:10.1016/j.maturitas.2012.05.002 · Cited by 23
“[63] Molitch ME, Clemmons DR, Malozowski S, et al.”
BackgroundInfluentialCurrò, D., Vergani, E., Bruno, C., Comi, S., d’Abate, C., & Mancini, A. (2020) · BioFactors · doi:10.1002/biof.1628 · Cited by 26
Normal and Aberrant Growth in Children
Cooke, D. W., DiVall, S. A., & Radovick, S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00024-1 · Cited by 31
Murray, P. G., Hague, C., Fafoula, O., Gleeson, H. K., Patel, L., Banerjee, I., Raabe, A. L., Hall, C. M., Wright, N. B., Amin, R., et al. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03554.x · Cited by 27
The impact of traumatic brain injury on pituitary function
Sundaram, N. K., Geer, E. B., & Greenwald, B. D. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.05.003 · Cited by 22
Doknić, M., Pekić, S., Miljić, D., Soldatović, I., POPOVIC, V. M., Stojanović, M., & Petakov, M. S. (2017) · International Journal of Endocrinology · doi:10.1155/2017/6969286 · Cited by 24
Insulin signaling in the whole spectrum of GH deficiency
Garmes, H. M., & Castillo, A. R. (2019) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000188 · Cited by 25
Oxytocin levels in response to pituitary provocation tests in healthy volunteers
Sailer, C. O., Winzeler, B. F., Urwyler, S. A., Schnyder, I., Refardt, J. C., Eckert, A., Varghese, N., Faßnacht, M., Chifu, I. O., Lawson, E. A., et al. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0346 · Cited by 23
Distinct Chromatin Configurations Regulate the Initiation and the Maintenance of hGH Gene Expression
Ho, Y., Shewchuk, B. M., Liebhaber, S. A., & Cooke, N. E. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01166-12 · Cited by 21
Budyal, S. R., Lila, A. R., Jalali, R., Gupta, T., Kasliwal, R., Jagtap, V. S., Bandgar, T., Menon, P. S. N., & Shah, N. S. (2013) · Pituitary · doi:10.1007/s11102-013-0466-4 · Cited by 22
“Although GH therapy has not been shown to improve increased mortality in patients with hypopituitarism, it definitely improves the quality of life of most patients [31].”
BackgroundCourtillot, C., Baudoin, R., Du Souich, T., Saatdjian, L., Tejedor, I., Pinto, G., Léger, J., Polak, M., Golmard, J.-L., Touraine, P., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0572 · Cited by 20
Roerink, S. H. P. P., Wagenmakers, M. A. E. M., Smit, J. W. A., van Rossum, E. F. C., Netea-Maier, R. T., Plantinga, T. S., & Hermus, A. R. M. M. (2016) · Endocrine · doi:10.1007/s12020-016-0883-z · Cited by 27
Allo Miguel, G., Serraclara Plá, A., Partida Muñoz, M. L., Martínez Díaz-Guerra, G., & Hawkins, F. (2016) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018816643908 · Cited by 22
Mukai, K., Kitamura, T., Tamada, D., Murata, M., Otsuki, M., & Shimomura, I. (2016) · Endocrine Journal · doi:10.1507/endocrj.ej16-0168 · Cited by 29
Pradhan, K. R., Chen, Y., Mostoufi‐Moab, S., Krull, K. R., Oeffinger, K. C., Sklar, C. A., Armstrong, G. T., Ness, K. K., Robison, L. L., Yasui, Y., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00627 · Cited by 25
Li, B., Wang, X., Yang, C., Wen, S., Li, J., Li, N., Long, Y., Mu, Y., Liu, J., Liu, Q., et al. (2021) · The EPMA Journal · doi:10.1007/s13167-021-00232-7 · Cited by 22
Severe growth hormone deficiency and empty sella in obesity: a cross-sectional study
Lubrano, C., Tenuta, M., Costantini, D., Specchia, P., Bárbaro, G., Basciani, S., Mariani, S., Pontecorvi, A., Lenzi, A., & Gnessi, L. (2015) · Endocrine · doi:10.1007/s12020-015-0530-0 · Cited by 25
Chanson, P., Cailleux-Bounacer, A., Kuhn, J.-M., Weryha, G., Chabre, O., Borson-Chazot, F., Dubois, S., Vincent-Dejean, C., Brue, T., Fedou, C., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0295 · Cited by 22
Role of pituitary dysfunction on cardiovascular risk in primary empty sella patients
Colao, A., Cotta, O. R., Ferone, D., Torre, M. L., Ferraù, F., Somma, C. D., Boschetti, M., Teti, C., Savanelli, M. C., Alibrandi, A., et al. (2012) · Clinical Endocrinology · doi:10.1111/cen.12122 · Cited by 24
Dubiel, R., Callender, L., Dunklin, C., Harper, C., Bennett, M., Kreber, L., Auchus, R., & Diaz-Arrastia, R. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00520 · Cited by 21
Approach to Testing Growth Hormone (GH) Secretion in Obese Subjects
POPOVIC, V. M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1099 · Cited by 23
Potential risks of glucagon stimulation test in elderly people
Tavares, A. B. W., Seixas-da-Silva, I. A., Silvestre, D. H., Paixão, C. M., Vaisman, M., & Conceição, F. L. (2014) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2014.11.002 · Cited by 23
“The insulin tolerance test (ITT) is considered to be the gold standard test for assessing GH reserve and has been recommended by several consensus guidelines [1–3], despite concerns regarding its safety, reproducibility, and specificity [4].”
MethodTransition of adolescents and young adults with endocrine diseases to adult health care
Kapellen, T. M., & Kieß, W. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.03.005 · Cited by 22
Mousa, A. A., Ghonem, M., EL-Hadidy, E., Azmy, E., Elbackry, M., El-Baiomy, A. A., Elzehery, R. R., Shaker, G. A., & Saleh, O. (2016) · Endocrine Research · doi:10.3109/07435800.2015.1068796 · Cited by 21
Gasco, V., Ferrero, A., Bisceglia, A., Prencipe, N., Cambria, V., Bioletto, F., Ghigo, E., Maccario, M., & Grottoli, S. (2020) · Neuroendocrinology · doi:10.1159/000508103 · Cited by 24
Does Imatinib Mesylate Therapy Cause Growth Hormone Deficiency?
Kebapçılar, L., Bilgir, O., Alacacıoğlu, İ., Payzın, B., Bilgir, F., Öner, P., Sarı, İ., Çalan, M., & Binicier, Ö. (2009) · Medical Principles and Practice · doi:10.1159/000226288 · Cited by 21
van Nieuwpoort, I. C., van Bunderen, C. C., Arwert, L. I., Franken, A. A. M., Koppeschaar, H. P. F., van der Lelij, A. J., Twisk, J. W. R., Boers, M., & Drent, M. L. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-0914 · Cited by 23
Growth Hormone as Biomarker in Heart Failure
Marra, A. M., Bobbio, E., D’Assante, R., Salzano, A., Arcopinto, M., Bossone, E., & Cittadini, A. (2017) · Heart Failure Clinics · doi:10.1016/j.hfc.2017.08.008 · Cited by 20
Primary empty sella and GH deficiency: prevalence and clinical implications.
Poggi, M., Monti, S., Lauri, C., Pascucci, C., Bisogni, V., & Toscano, V. (2012) · PubMed · doi:10.4415/ann_12_01_15 · Cited by 24
Brabant, G. E., Rasmussen, Å. K., Biller, B. M. K., Buchfelder, M., Feldt‐Rasmussen, U., Forssmann, K., Jönsson, B., Kołtowska‐Häggström, M., Maiter, D. M., Saller, B., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0153 · Cited by 21
Pituitary Adenoma: A Clinician’S Perspective
Vance, M. L. (2008) · Endocrine Practice · doi:10.4158/ep.14.6.757 · Cited by 20
Self-citationDepth and duration of hypoglycaemia achieved during the insulin tolerance test
Ajala, O., Lockett, H., Twine, G., & Flanagan, D. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0068 · Cited by 23
Effects of Growth Hormone Administration on Muscle Strength in Men over 50 Years Old
Tavares, A. B. W., Micmacher, E., Biesek, S., Assumpção, R. P., Redorat, R. G., Veloso, Ú., Vaisman, M., Farinatti, P., & Conceição, F. L. (2013) · International Journal of Endocrinology · doi:10.1155/2013/942030 · Cited by 25
Holdaway, I. M., Hunt, P. J., Manning, P. J., Cutfield, W. S., Gamble, G. D., Ninow, N., Staples‐Moon, D., Moodie, P. M., & Metcalfe, S. (2014) · Clinical Endocrinology · doi:10.1111/cen.12691 · Cited by 20
Klose, M., Stochholm, K., Janukonyté, J., Christensen, L. L., Cohen, A. S., Wagner, A., Laurberg, P., Christiansen, J. S., Andersen, M., & Feldt-Rasmussen, U. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-1069 · Cited by 20
Valassi, E., García‐Giralt, N., Malouf, J., Crespo, I., Llauger, J., Díez‐Pérez, A., & Webb, S. M. (2019) · Endocrine Connections · doi:10.1530/ec-18-0482 · Cited by 21
Pamphlett, R., Jew, S. K., Doble, P., & Bishop, D. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00419 · Cited by 21
Patient preferences for growth hormone treatment in Japanese children
Tanaka, T., Sato, T., Yuasa, A., Akiyama, T., & Tawseef, A. (2021) · Pediatrics International · doi:10.1111/ped.14760 · Cited by 20
Yuen, K. C. J., Kołtowska‐Häggström, M., Cook, D. M., Fox, J. L., Jönsson, P., Geffner, M. E., & Abs, R. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3631 · Cited by 20
Varewijck, A. J., Lamberts, S. W. J., van der Lely, A. J., Neggers, S. J. C. M. M., Hofland, L. J., & Janssen, J. A. M. J. L. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2558 · Cited by 20
Friedrich, N., Nauck, M. A., Schipf, S., Völzke, H., Brabant, G. E., & Wallaschofski, H. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2412 · Cited by 21
Bianchi, A., Giampietro, A., Tartaglione, L., Chiloiro, S., Gentilella, R., Bima, C., Anile, C., Olivi, A., Pontecorvi, A., & Marinis, L. D. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12692 · Cited by 19
Combined Effects of Growth Hormone and Testosterone Replacement Treatment in Heart Failure
Salzano, A., Marra, A. M., Arcopinto, M., D’Assante, R., Triggiani, V., Coscioni, E., Pasquali, D., Rengo, G., Suzuki, T., Bossone, E., et al. (2019) · ESC Heart Failure · doi:10.1002/ehf2.12520 · Cited by 20
The heart in growth hormone (GH) deficiency and the cardiovascular effects of GH
Chanson, P. (2020) · Annales d Endocrinologie · doi:10.1016/j.ando.2020.03.005 · Cited by 22
Pituitary stalk interruption syndrome
Voutetakis, A. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-820683-6.00002-6 · Cited by 29
Hu, W., Qiu, B., Mei, F., Mao, J., Zhou, L., Liu, F., Fan, J., Liu, Y., Wen, G., Qi, S., et al. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-2924 · Cited by 19
A 2024 Update on Growth Hormone Deficiency Syndrome in Adults: From Guidelines to Real Life
Aversa, L. S., Cuboni, D., Grottoli, S., Ghigo, E., & Gasco, V. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13206079 · Cited by 25
“These kind of side effects were more commonly seen when weight-based dosing was used, now they are a signal of likely overdosing and usually recede after lowering dosage or after a brief pause from therapy, starting lower at resumption [2,3].”
BackgroundMethodInfluentialPoggi, M., Pascucci, C., Monti, S., Pugliese, P., Lauri, C., Amodeo, G., Girelli, G., & Toscano, V. (2010) · Journal of Endocrinological Investigation · doi:10.1007/bf03346643 · Cited by 20
Scacchi, M., Orsini, F., Cattaneo, A., Grasso, A., Filippini, B., Giraldi, F. P., Fatti, L. M., Moro, M., & Cavagnini, F. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0160 · Cited by 21
Focus on GH deficiency and thyroid function
Giavoli, C., Profka, E., Rodari, G., Lania, A. G., & Beck-Peccoz, P. (2017) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2017.02.003 · Cited by 21
Preoperative assessment for pituitary surgery
Pereira, O., & Bevan, J. S. (2008) · Pituitary · doi:10.1007/s11102-008-0093-7 · Cited by 19
Mancini, A., Vergani, E., Bruno, C., Palladino, A., & Brunetti, A. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00416 · Cited by 19
Growth hormone levels in the diagnosis of growth hormone deficiency in adulthood
Corneli, G., Gasco, V., Prodam, F., Grottoli, S., Aimaretti, G., & Ghigo, E. (2007) · Pituitary · doi:10.1007/s11102-007-0031-0 · Cited by 22
Hartman, M. L., Weltman, A., Zagar, A., Qualy, R. L., Hoffman, A. R., & Merriam, G. R. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1430 · Cited by 19
Self-citationGrowth hormone deficiency in patients with obesity
Salvatori, R. (2015) · Endocrine · doi:10.1007/s12020-015-0571-4 · Cited by 19
Höybye, C. (2023) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2023.101788 · Cited by 26
Shimatsu, A., Tai, S., Imori, M., Ihara, K., Taketsuna, M., Funai, J., Tanaka, T., Teramoto, A., Irie, M., & Chihara, K. (2013) · Endocrine Journal · doi:10.1507/endocrj.ej13-0083 · Cited by 20
Feldt‐Rasmussen, U., Brabant, G. E., Maiter, D. M., Jönsson, B., Toogood, A. A., Kołtowska‐Häggström, M., Rasmussen, Å. K., Buchfelder, M., Saller, B., & Biller, B. M. K. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0005 · Cited by 19
Ku, C. R., Brue, T. C., Schilbach, K., Ignatenko, S., Magony, S., Chung, Y., Kim, B.-J., Hur, K. Y., Kang, H., Kim, J. H., et al. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0185 · Cited by 18
Metadata
- Authors
- Molitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., & Vance, M. L.
- Affiliations
- Northwestern University (US)
- University of North Carolina at Chapel Hill (US)
- University of Washington (US)
- University of Virginia (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-06
- Volume
- 96
- Issue
- 6
- Pages
- 1587-1609
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2090627812
- Semantic Scholar
- 82180f0f73f275a6a0e865c2c46af465e9dc1fc8
- Cited by
- 1,047
- References
- 207
- Citations by year
- 2026: 31 · 2025: 43 · 2024: 46 · 2023: 53 · 2022: 59 · 2021: 61 · 2020: 59 · 2019: 59 · 2018: 64 · 2017: 56 · 2016: 66 · 2015: 63 · 2014: 61 · 2013: 75 · 2012: 42
- FWCI
- 57.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- adult growth hormone deficiency, growth hormone therapy, body composition, exercise capacity, skeletal integrity, quality of life, treatment risks and benefits
- MeSH terms
- Adult, Dwarfism, Pituitary, Humans, Evidence-Based Medicine, Human Growth Hormone, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.